{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:25:07Z","timestamp":1793384707679,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.remnie.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T16:23:00Z","timestamp":1685636580000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of results after 112 radioembolizations with 90Y-microspheres"],"prefix":"10.1016","volume":"42","author":[{"given":"I.","family":"Cas\u00e1ns-Tormo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guijarro-Rosaleny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lluch-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rodr\u00edguez-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rosell\u00f3-Ker\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Asensio-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2023.05.004_bib0005","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid."},{"key":"10.1016\/j.remnie.2023.05.004_bib0010","author":"Benson"},{"key":"10.1016\/j.remnie.2023.05.004_bib0015","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/jcm12052072","article-title":"Stage IV colorectal cancer management and treatment","volume":"12","author":"Hernandez","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.remnie.2023.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging I."},{"key":"10.1016\/j.remnie.2023.05.004_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/a-1759-4238","article-title":"Radioembolization, principles and indications","volume":"61","author":"Ahmadzadehfar","year":"2022","journal-title":"Nuklearmedizin."},{"key":"10.1016\/j.remnie.2023.05.004_bib0030","first-page":"164","article-title":"Transarterial radioembolization with Yttrium-90: current status and future prospects","volume":"8","author":"Yang","year":"2020","journal-title":"Gastroenterol Rep(Oxf)."},{"key":"10.1016\/j.remnie.2023.05.004_bib0035","first-page":"370","article-title":"Radioembolizaci\u00f3n en tumores hep\u00e1ticos","volume":"38","author":"Carrion-Martin","year":"2019","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00259-015-3157-8","article-title":"Clinical impact of (99m)Tc-MAA SPECT\/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres","volume":"43","author":"Garin","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2023.05.004_bib0045","first-page":"1209","article-title":"Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations","volume":"47","author":"Gulec","year":"2006","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2023.05.004_bib0050","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalized selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2023.05.004_bib0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.remnie.2023.05.004_bib0060","first-page":"69","article-title":"\u00bfEst\u00e1 todo dicho en el tratamiento de las met\u00e1stasis hep\u00e1ticas del c\u00e1ncer colorrectal con radioembolizaci\u00f3n, tras los resultados del EPOCH?","volume":"41","author":"Orcajo-Rincon","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0065","article-title":"Predictors of successful Yttrium-90 radioembolization bridging or downstaging in patients with hepatocellular carcinoma","volume":"22","author":"Villalobos","year":"2021","journal-title":"Can J Gastroenterol Hepatol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0070","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/cancers14040959","article-title":"Radioembolization of hepatocellular carcinoma with 90Y glass microspheres: no advantage of voxel dosimetry with respect to mean dose in dose-response analysis with two radiological methods","volume":"14","author":"Roman\u00f2","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"Suppl 1","key":"10.1016\/j.remnie.2023.05.004_bib0075","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/s00259-013-2675-5","article-title":"The role of SPECT\/CT in radioembolization of liver tumours","volume":"41","author":"Ahmadzadehfar","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2023.05.004_bib0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.remnie.2023.05.004_bib0085","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s00261-021-03100-0","article-title":"Imaging of treatment response during systemic therapy for hepatocellular carcinoma","volume":"46","author":"Masch","year":"2021","journal-title":"Abdom Radiol (NY)."},{"key":"10.1016\/j.remnie.2023.05.004_bib0090","first-page":"77","article-title":"EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres","volume":"8","author":"Chiesa","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2023.05.004_bib0095","first-page":"244","article-title":"Radioembolizaci\u00f3n de tumores hep\u00e1ticos con (90)Y-microesferas","volume":"34","author":"Rodr\u00edguez-Fraile","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0100","article-title":"Radiation pneumonitis following Yttrium-90 radioembolization: a Korean multicenter study","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0105","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5, Bethesda, MD: US Department of Health and Human Services; 2018."},{"key":"10.1016\/j.remnie.2023.05.004_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00270-020-02642-y","volume":"44","author":"Helmberger","year":"2021","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0115","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology."},{"key":"10.1016\/j.remnie.2023.05.004_bib0120","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1200\/JCO.21.01839","article-title":"EPOCH Investigators. Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial","volume":"39","author":"Mulcahy","year":"2021","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13543784.2022.2009455","article-title":"Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials","volume":"31","author":"Di Federico","year":"2022","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1016\/j.remnie.2023.05.004_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/diagnostics11010122","article-title":"Transarterial radioembolization of hepatocellular carcinoma, liver-dominant hepatic colorectal cancer metastases, and cholangiocarcinoma using yttrium90 microspheres: eight-year single-center real-life experience","volume":"11","author":"Pellegrinelli","year":"2021","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.remnie.2023.05.004_bib0135","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.3390\/jcm11247469","article-title":"Improved survival after transarterial radioembolisation for hepatocellular carcinoma gives the procedure added value","volume":"11","author":"Mosconi","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.remnie.2023.05.004_bib0140","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jvir.2021.08.009","article-title":"Neoadjuvant yttrium-90 transarterial radioembolization with resin microspheres prescribed using the medical internal radiation dose model for intrahepatic cholangiocarcinoma","volume":"32","author":"Sarwar","year":"2021","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0145","first-page":"231","article-title":"Biomarcadores asociados con la supervivencia y la respuesta terap\u00e9utica a la radioembolizaci\u00f3n con esferas cargadas de itrio-90 en las met\u00e1stasis hep\u00e1ticas del carcinoma colorrectal: nuestra experiencia","volume":"41","author":"Trivi\u00f1o-Ib\u00e1\u00f1ez","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0150","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00270-022-03254-4","article-title":"Study protocol: efficacy and safety of radioembolization (REM) as an early modality (EM) therapy for metastatic breast cancer (BR) to the liver with Y90 (REMEMBR Y90)","volume":"45","author":"Wu","year":"2022","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0155","first-page":"82","article-title":"Eficacia y seguridad de la radioembolizaci\u00f3n con 90Y en el tratamiento de met\u00e1stasis hep\u00e1ticas de tumores neuroendocrinos. Seguimiento a largo plazo y repercusi\u00f3n en la supervivencia","volume":"40","author":"Tudela-Lerma","year":"2021","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jvir.2020.02.008","article-title":"Yttrium-90 radioembolization in intrahepatic cholangiocarcinoma: a multicenter retrospective analysis","volume":"31","author":"Buettner","year":"2020","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00268-016-3682-z","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma prior to liver transplantation","volume":"41","author":"Ettorre","year":"2017","journal-title":"World J Surg."},{"key":"10.1016\/j.remnie.2023.05.004_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/cancers15030733","article-title":"Liver resection and transplantation following yttrium-90 radioembolization for primary malignant liver tumors: a 15-year single-center experience","volume":"15","author":"Aliseda","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.remnie.2023.05.004_bib0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","article-title":"Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution","volume":"31","author":"Salem","year":"2008","journal-title":"Am J Clin Oncol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0185","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.29207","article-title":"Prevention and treatment of complications of selective internal radiation therapy: expert guidance and systematic review","volume":"66","author":"Sangro","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.remnie.2023.05.004_bib0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MEG.0000000000000772","article-title":"Radioembolization-induced liver disease: a systematic review","volume":"29","author":"Braat","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.remnie.2023.05.004_bib0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/RLU.0000000000002828","article-title":"Incidence of radioembolization-induced liver disease and liver toxicity following repeat 90Y-radioembolization: outcomes at a large tertiary care center","volume":"45","author":"Elsayed","year":"2020","journal-title":"Clin Nucl Med."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:47Z","timestamp":1762418747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808923000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2253808923000538"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2023.05.004","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of results after 112 radioembolizations with 90Y-microspheres","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2023.05.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}